Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

SEC Filings

Document Details

Form

DEF 14A

Filing Date

Apr 1, 2002

Document Date

May 3, 2002

Form Description

Official notification to shareholders of matters to be brought to a vote ("Proxy")

Filing Group

Proxy Filings

Company

Charles River Laboratories International, Inc.

Issuer

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Filing Formats

View HTML

Download PDF

Download DOC

Featured Reports

2025 Annual Report
View PDF
Print PDF

Charles River Corporate Citizenship Report
View PDF
Print PDF